377 related articles for article (PubMed ID: 32683301)
21. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
[TBL] [Abstract][Full Text] [Related]
22. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
Wan B; Liu B; Huang Y; Lv C
Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
[TBL] [Abstract][Full Text] [Related]
23. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
24. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
25. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
26. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
27. Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications.
Wang Q; Hu J; Kang W; Wang J; Xiang Y; Fu M; Gao H; Huang Z
Medicine (Baltimore); 2021 Mar; 100(11):e24949. PubMed ID: 33725966
[TBL] [Abstract][Full Text] [Related]
28. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Front Oncol; 2021; 11():630706. PubMed ID: 33968730
[TBL] [Abstract][Full Text] [Related]
29. The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.
Li J; Cao J; Liang C; Deng R; Li P; Tian J
Med Oncol; 2022 Jan; 39(4):41. PubMed ID: 35092501
[TBL] [Abstract][Full Text] [Related]
30. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
Wu Y; Li X
Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
[TBL] [Abstract][Full Text] [Related]
31. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
Zhang M; Zhang J; Liang X; Zhang M
BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract][Full Text] [Related]
33. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Hu D; Zhou M; Zhu X
Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
Gu YY; Chen G; Lin P; Cheng JW; Huang ZG; Luo J; Zhai GQ; Wang YL; Yan HB; Li SH
Cancer Biomark; 2020; 27(2):265-275. PubMed ID: 31929144
[TBL] [Abstract][Full Text] [Related]
35. Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy.
Xiang Z; Shen E; Li M; Hu D; Zhang Z; Yu S
Bioengineered; 2021 Dec; 12(1):1773-1790. PubMed ID: 34002666
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of
Wang T; Xie F; Li YH; Liang B
Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
[TBL] [Abstract][Full Text] [Related]
39. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
Yuan X; He Y; Luo C; Wang W
Invest New Drugs; 2022 Apr; 40(2):232-244. PubMed ID: 34633577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]